Abstract
Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Current Pharmaceutical Design
Title:A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine
Volume: 22 Issue: 23
Author(s): Thanh D. Van, Nhut Tran, Ly Le and Frank Eisenhaber
Affiliation:
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Abstract: Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Export Options
About this article
Cite this article as:
D. Van Thanh, Tran Nhut, Le Ly and Eisenhaber Frank, A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine, Current Pharmaceutical Design 2016; 22 (23) . https://dx.doi.org/10.2174/1381612822666160419144352
DOI https://dx.doi.org/10.2174/1381612822666160419144352 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Exploring New CGRP Family Peptides and their Receptors in Vertebrates
Current Protein & Peptide Science TTR Fibril Formation Inhibitors: Is there a SAR?
Current Medicinal Chemistry Editorial (Hot Topic: Treatment of Inflammatory Bowel Diseases: Where Do We Go from here?)
Current Drug Delivery Natural Antiulcerogenic Agents: An Overview
Current Bioactive Compounds GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Regulators of Stem Cells Proliferation in Tissue Regeneration
Current Stem Cell Research & Therapy Modulation of Neuro-Inflammation and Vascular Response by Oxidative Stress Following Cerebral Ischemia-Reperfusion Injury
Current Medicinal Chemistry Humoral and Mechanical Cross-Talk in the Vasculature: Perspectives in Vascular Disease
Vascular Disease Prevention (Discontinued) Monoclonal Antibodies in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Application of Small Molecules/Macromolecules in Ocular Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vitamin D Deficiency: The Invisible Accomplice of Metabolic Endotoxemia?
Current Pharmaceutical Design BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Acute Phase Proteins and their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
Protein & Peptide Letters Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology The Role of Nitric Oxide (NO) in Control of LHRH Release that Mediates Gonadotropin Release and Sexual Behavior
Current Pharmaceutical Design Editorial: [Hot Topic: Epigenetics in Arthritis]
Current Rheumatology Reviews Targeting Microglial Polarization to Improve TBI Outcomes
CNS & Neurological Disorders - Drug Targets Review of the Relationship between Renal and Retinal Microangiopathy in Diabetes Mellitus Patients
Current Diabetes Reviews